The way forward for drug-resistant tuberculosis in the Philippines

Lancet Infect Dis. 2022 Jun;22(6):760. doi: 10.1016/S1473-3099(22)00285-7.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antitubercular Agents / therapeutic use
  • Humans
  • Philippines / epidemiology
  • Tuberculosis, Multidrug-Resistant* / drug therapy
  • Tuberculosis, Multidrug-Resistant* / epidemiology

Substances

  • Antitubercular Agents